GHRP-6

Mod GRF 1-29, also known as CJC-1295 without DAC, is a synthetic GHRH analog with the same first 29 amino acids as endogenous GHRH plus stabilizing modifications. Short half-life (~30 min) preserves natural pulsatile GH release.

Pre-combined Mod GRF 1-29 (CJC-1295 without DAC) + Ipamorelin research blend in a single vial. Combines a GHRH analogue with a GHSR agonist for defined GH-axis experiments.

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino-acid IGF-1 analogue with an N-terminal extension and Arg3 substitution. It is used to investigate growth-factor signalling and IGF-binding-protein interactions in defined cellular models. For laboratory research only.

Sermorelin, also called GRF 1-29, is the first 29 amino acids of growth hormone-releasing hormone (GHRH), the shortest fragment that keeps the full hormone's receptor activity. It is studied as a GHRH receptor agonist in growth hormone axis research.